LONGEVERON LLC Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Letter Agreement between Longeveron, Inc. and Nataliya Agafonova, M.D. dated June 21, 2023 (Filed With SEC on February 27, 2024)
- Letter Agreement between Longeveron, Inc. and Lisa Locklear, dated July 14,2023 (Filed With SEC on February 27, 2024)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2024)
- Dealer-Manager Agreement, dated August 14, 2023, between Longeveron Inc. and R.F. Lafferty & Co., Inc (Filed With SEC on August 18, 2023)
- Form of Dealer-Manager Agreement with R.F. Lafferty & Co. Inc (Filed With SEC on July 28, 2023)
- Agreement, dated February 22, 2023 (Filed With SEC on February 28, 2023)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2022)
- Underwriter Warrants issued February 17, 2021 (Filed With SEC on March 30, 2021)
- Certificate of Conversion of Longeveron LLC (Filed With SEC on March 30, 2021)
- Plan of Conversion (Filed With SEC on March 30, 2021)
- Form of Underwriter Warrants (Filed With SEC on February 3, 2021)
- Form of Certificate of Conversion of Longeveron LLC (Filed With SEC on February 3, 2021)
- Form of Plan of Conversion (Filed With SEC on February 3, 2021)
- National Institutes of Health Grant to University of Maryland Baltimore, dated September 9, 2020 (Filed With SEC on January 19, 2021)
- National Institutes of Health Grant to Longeveron LLC, dated June 24, 2020 (Filed With SEC on January 19, 2021)
- National Institutes of Health Grant to Longeveron LLC, dated April 26, 2019 (Filed With SEC on January 19, 2021)
- Alzheimers Association Grant to Longeveron LLC, dated April 1, 2019 (Filed With SEC on January 19, 2021)
